{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:21:32Z","timestamp":1707783692661},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2024,2,1]]},"DOI":"10.1001\/jamaneurol.2023.5086","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T16:01:35Z","timestamp":1704729695000},"page":"113","source":"Crossref","is-referenced-by-count":0,"title":["The Case of Anticoagulation for Progressing Stroke"],"prefix":"10.1001","volume":"81","author":[{"given":"Brett","family":"Cucchiara","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Majersik","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Utah, Salt Lake City"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"4","key":"ned230024r1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1212\/WNL.11.4_Part_2.119","article-title":"Anticoagulant therapy in cerebral thrombosis and cerebral embolism. a national cooperative study, interim report.","volume":"11","author":"Fisher","year":"1961","journal-title":"Neurology"},{"key":"ned230024r2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1212\/WNL.12.12.823","article-title":"Anticoagulant therapy in cerebral infarction. report on cooperative study.","volume":"12","author":"Baker","year":"1962","journal-title":"Neurology"},{"issue":"9065","key":"ned230024r3","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke.","volume":"349","author":"International Stroke Trial Collaborative Group","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"ned230024r4","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1161\/01.STR.31.7.1770","article-title":"Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials.","volume":"31","author":"Bath","year":"2000","journal-title":"Stroke"},{"issue":"20","key":"ned230024r5","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1161\/CIRCULATIONAHA.107.181486","article-title":"Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association\/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.","volume":"115","author":"Adams","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"ned230024r6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1212\/WNL.53.1.122","article-title":"Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).","volume":"53","author":"Adams","year":"1999","journal-title":"Neurology"},{"issue":"5","key":"ned230024r7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(07)70079-0","article-title":"Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study.","volume":"6","author":"Wong","year":"2007","journal-title":"Lancet Neurol"},{"issue":"11","key":"ned230024r8","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1161\/01.STR.0000185730.50480.e7","article-title":"Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions.","volume":"36","author":"Camerlingo","year":"2005","journal-title":"Stroke"},{"issue":"3","key":"ned230024r9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA.","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"ned230024r10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"ned230024r11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA.","volume":"383","author":"Johnston","year":"2020","journal-title":"N Engl J Med"},{"key":"ned230024r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.5093","article-title":"Argatroban in patients with acute ischemic stroke with early neurological deterioration: a randomized clinical trial.","author":"Zhang","journal-title":"JAMA Neurol"},{"issue":"8","key":"ned230024r13","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jama.2023.0550","article-title":"Effect of argatroban plus intravenous alteplase vs intravenous alteplase alone on neurologic function in patients with acute ischemic stroke: the ARAIS randomized clinical trial.","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"issue":"14","key":"ned230024r14","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease.","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"ned230024r15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jamaneurol.2020.4557","article-title":"Prediction of early neurological deterioration in individuals with minor stroke and large vessel occlusion intended for intravenous thrombolysis alone.","volume":"78","author":"Seners","year":"2021","journal-title":"JAMA Neurol"},{"issue":"10329","key":"ned230024r16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(22)00014-9","article-title":"Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.","volume":"399","author":"van der Steen","year":"2022","journal-title":"Lancet"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2813361\/jamaneurology_cucchiara_2024_ed_230024_1707344409.73052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T16:02:09Z","timestamp":1707753729000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2813361"}},"subtitle":["Have We Come Full Circle?"],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2023.5086","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}